Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Leads Biolabs Lists on HKEX, Raising USD 189 Million Through Initial Public Offering

  • Nanjing Leads Biolabs Co., Ltd. listed on the Main Board of The Stock Exchange of Hong Kong Limited on July 25, 2025, under the stock code 09887.
  • The IPO was priced at HKD 35 per share and raised approximately USD 189 million, including the green shoe option.
  • Leads Biolabs plans to use the funds primarily for ongoing clinical trials and regulatory affairs, with 65% allocated for this purpose.
  • The company aims to become a global leader in immuno-oncology therapeutics to address severe diseases in China and worldwide.
Insights by Ground AI
Does this summary seem wrong?

78 Articles

LoudounTimes.comLoudounTimes.com
+77 Reposted by 77 other sources
Center

Leads Biolabs Lists on HKEX, Raising USD 189 Million Through Initial Public Offering

NANJING, China, July 24, 2025 /PRNewswire/ -- On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company") listed on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX) under the stock…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 58% of the sources are Center
58% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Friday, July 25, 2025.
Sources are mostly out of (0)

Similar News Topics

Nanjing icon

Nanjing

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal